John Harry Cross III - Dec 15, 2021 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Financial Officer
Signature
/s/ John Harry Cross III, power of attorney
Stock symbol
SONN
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
4
Date filed
4/8/2022, 04:30 PM
Next filing
Dec 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +67K +85.6% 145K Dec 15, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 15, 2021, the Reporting Person was granted 66,951 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.
F2 Includes unvested RSUs.